Sutro Biopharma (STRO) Return on Invested Capital (2022 - 2025)

Sutro Biopharma's Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.01% for Q4 2025.

• In Q4 2025, Return on Invested Capital changed N/A year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (changed N/A YoY), while the FY2025 annual figure was 0.04%, changed N/A from the prior year.
• Return on Invested Capital came in at 0.01% for Q4 2025 at Sutro Biopharma, down from 0.03% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.07% in Q2 2025 to a low of 0.01% in Q3 2023.
• A 4-year average of 0.0% and a median of 0.01% in 2023 frame the typical range for Return on Invested Capital.
• Across the five-year window, Return on Invested Capital changed 0 bps in 2023 and climbed 7 bps in 2025, its largest moves.
• Sutro Biopharma's Return on Invested Capital stood at 0.01% in 2022, then sank by 41 bps to 0.01% in 2023, then tumbled by 46 bps to 0.01% in 2024, then jumped by 227 bps to 0.01% in 2025.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.01%, 0.03%, and 0.07% for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison